Clinical Trial Update: Humanized CAR-T Therapy for Treatment of B Cell Malignancy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a humanized CAR-T cell therapy for chronic lymphocytic leukemia (a B-cell leukemia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Humanized CAR-T therapy (CAR-T cell therapy (humanized))

Snippet

Sponsor: Kai Lin Xu; Jun Nian Zheng | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1, Phase 2 | Status: UNKNOWN